SCHEMBL24387104

SCHEMBL24387104

CCN[C@H](C)c1cc(-c2cn3ccnc3c(Cl)n2)c(OC)cn1

nearest known ligand 0.47

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ HCRTR2 O43614 7/20 0.47
▸ PDE3B Q13370 1/20 0.35
▸ PDE3A Q14432 1/20 0.35
▸ SYK P43405 7/20 0.34
▸ CD63 P08962 2/20 0.34
▸ SUV39H2 Q9H5I1 5/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29102897 1.00 HCRTR2 (0.47) HCRTR2PDE3BPDE3ASYKCD63
SCHEMBL24529568 0.89 HCRTR2 (0.57) HCRTR2PDE3BPDE3ASYKCD63
SCHEMBL24386929 0.83 HCRTR2 (0.49) HCRTR2PDE3BPDE3ASYKCD63
SCHEMBL24386983 0.83 HCRTR2 (0.48) HCRTR2PDE3BPDE3ASYKCD63
SCHEMBL29750202 0.83 HCRTR2 (0.48) HCRTR2PDE3BPDE3ASYKCD63
SCHEMBL24387056 0.82 HCRTR2 (0.34) HCRTR2
Hydrochloric Acid SCHEMBL29750119 0.82 HCRTR2 (0.33) HCRTR2
SCHEMBL29749888 0.81 HCRTR2 (0.44) HCRTR2PDE3BPDE3ASYKCD63
SCHEMBL24387658 0.81 HCRTR2 (0.52) HCRTR2PDE3BPDE3ASYKCD63
SCHEMBL24387380 0.80 HCRTR2 (0.39) HCRTR2PDE3BPDE3ASYKCD63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4236938-A1 MACROCYCLIC UREA OREXIN RECEPTOR AGONISTS Merck Sharp & Dohme LLC (US) 2023-09-06 — — EP disclosed
CN-116600803-A Macrocyclic urea orexin receptor agonists 默沙东有限责任公司 2023-08-15 — — CN disclosed
WO-2022094012-A1 MACROCYCLIC UREA OREXIN RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2022-05-05 — — WO disclosed
WO-2022094012-A1 MACROCYCLIC UREA OREXIN RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2022-05-05 — — WO disclosed
Send feedback